BioSpace News Archive

Drug Development

Medical Research Council Funds Phase 2 Multi-Center Study of XBiotech’s Bermekimab in Advanced Cancer Patients

Medical Research Council (MRC) Grants Funding for Bermekimab as Part of its Support for “Outstanding Clinical Programs in the United Kingdom”

July 9, 2019
·
4 min read
Policy

CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data

CorMedix Inc. announced that it has received feedback from the U.S. FDA regarding the submitted statistical analyses of data and additional information requested by the FDA for the primary and secondary efficacy endpoints of the Company’s LOCK-IT-100 clinical study.

July 9, 2019
·
4 min read
Business

Tennesseans Reaping Benefits of Novel Clinical Trials Network in Year One of Operation

Tennessee’s innovative clinical trials network is soaring just one year into operations, bringing growing benefits for Tennesseans and the advancement of health care across the state.

July 9, 2019
·
4 min read
Genetown

Arbor Biotechnologies Selected For MIT STEX25

Biodiscovery company joins MIT accelerator for high-potential startups

July 9, 2019
·
2 min read
Drug Development

Nanobiotix Announces Publication of Phase III Soft Tissue Sarcoma Data for First-in-class NBTXR3 in the Lancet Oncology

NANOBIOTIX announced that the previously reported results from the Phase II/III Act.In.Sarc trial evaluating NBTXR3 in patients with advanced STS have been published online in The Lancet Oncology.

July 9, 2019
·
7 min read
Deals

Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split

Nephros, Inc., a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, announced preliminary financial results for the quarter ended June 30, 2019.

July 9, 2019
·
5 min read
Policy

Judge Strikes Down Trump’s Rule Mandating Drug Price Disclosure in TV Ads

The judge ruled that the U.S. Department of Health and Human Services did not have the authority to compel companies to disclose the list prices without Congressional approval.

July 9, 2019
·
3 min read
·
Alex Keown
BioCapital

PhRMA-backed Study Shows Hospitals Significantly Hike Drug Prices

The study data shows that the amount hospitals receive after negotiations with commercial payers is, on average, almost twice what they paid to acquire the medicine.

July 9, 2019
·
2 min read
·
Alex Keown
Immunotherapy could work against bowel cancers resistant to important targeted treatment

Patients with bowel cancer who have stopped responding to a widely used targeted drug could benefit from immunotherapy, a major new study reveals.

July 9, 2019
·
7 min read
Business

Commuting Can Become a Waiting Game in These Biotech Hubs

A recent report from Business Insider ranked the 50 worst places in the United States for traffic commutes and the main biotech hubs were all included.

July 9, 2019
·
4 min read
·
Alex Keown